These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 12631372)
21. Effects of Native Fucosylated Glycosaminoglycan, Its Depolymerized Derivatives on Intrinsic Factor Xase, Coagulation, Thrombosis, and Hemorrhagic Risk. Zhou L; Gao N; Sun H; Xiao C; Yang L; Lin L; Yin R; Li Z; Zhang H; Ji X; Zhao J Thromb Haemost; 2020 Apr; 120(4):607-619. PubMed ID: 32289860 [TBL] [Abstract][Full Text] [Related]
22. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio]. Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657 [TBL] [Abstract][Full Text] [Related]
23. Depolymerized holothurian glycosaminoglycan (DHG) prevents neointimal formation in balloon-injured rat carotid artery. Igarashi M; Takeda Y; Mori S; Takahashi K; Fuse T; Yamamura M; Saito Y Atherosclerosis; 1997 Feb; 129(1):27-31. PubMed ID: 9069513 [TBL] [Abstract][Full Text] [Related]
24. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo. Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450 [TBL] [Abstract][Full Text] [Related]
25. Nafamostat mesilate: a regional anticoagulant for hemodialysis in patients at high risk for bleeding. Akizawa T; Koshikawa S; Ota K; Kazama M; Mimura N; Hirasawa Y Nephron; 1993; 64(3):376-81. PubMed ID: 8341382 [TBL] [Abstract][Full Text] [Related]
26. Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism. Sheehan JP; Walke EN Blood; 2006 May; 107(10):3876-82. PubMed ID: 16672689 [TBL] [Abstract][Full Text] [Related]
27. Hemodialysis with a dialyzer loaded with argatroban may be performed in vivo without a systemic anticoagulant. Zhang Y; Ning J; Veeraragoo P; Li Y; Dai S Blood Purif; 2012; 33(4):300-6. PubMed ID: 22652560 [TBL] [Abstract][Full Text] [Related]
28. A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin. Anastassiades E; Ireland H; Flynn A; Lane DA; Curtis JR Nephrol Dial Transplant; 1990; 5(2):135-40. PubMed ID: 2162506 [TBL] [Abstract][Full Text] [Related]
29. The use of PEG-Hirudin in chronic hemodialysis monitored by the Ecarin Clotting Time: influence on clotting of the extracorporeal system and hemostatic parameters. Ulbricht K; Bucha E; Pöschel KA; Stein G; Wolf G; Nowak G Clin Nephrol; 2006 Mar; 65(3):180-90. PubMed ID: 16550749 [TBL] [Abstract][Full Text] [Related]
30. Effect of anticoagulation on blood membrane interactions during hemodialysis. Hofbauer R; Moser D; Frass M; Oberbauer R; Kaye AD; Wagner O; Kapiotis S; Druml W Kidney Int; 1999 Oct; 56(4):1578-83. PubMed ID: 10504511 [TBL] [Abstract][Full Text] [Related]
31. Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter. Arcangeli A; Rocca B; Salvatori G; Ciancia M; De Cristofaro R; Antonelli M Thromb Res; 2010 Jul; 126(1):24-31. PubMed ID: 20185164 [TBL] [Abstract][Full Text] [Related]
32. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride. Andrassy K Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S39-43. PubMed ID: 8180328 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and Pharmacodynamics of a Depolymerized Glycosaminoglycan from Liu S; Zhang T; Sun H; Lin L; Gao N; Wang W; Li S; Zhao J Mar Drugs; 2021 Apr; 19(4):. PubMed ID: 33920475 [TBL] [Abstract][Full Text] [Related]
35. Anticoagulation in intermittent hemodialysis: pathways, protocols, and pitfalls. Ross S Vet Clin North Am Small Anim Pract; 2011 Jan; 41(1):163-75. PubMed ID: 21251516 [TBL] [Abstract][Full Text] [Related]
36. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin. Atkinson HM; Mewhort-Buist TA; Berry LR; Chan AK Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069 [TBL] [Abstract][Full Text] [Related]
37. Low molecular weight heparin in hemodialysis patients with a bleeding tendency. Leu JG; Chiang SS; Lin SM; Pai JK; Jiang WW Nephron; 2000 Dec; 86(4):499-501. PubMed ID: 11124600 [TBL] [Abstract][Full Text] [Related]
38. Enoxaparin versus unfractioned heparin as anticoagulant for continuous venovenous hemodialysis: a randomized open-label trial. Garcés EO; Victorino JA; Thomé FS; Röhsig LM; Dornelles E; Louzada M; Stifft J; de Holanda F; Veronese FV Ren Fail; 2010 Jan; 32(3):320-7. PubMed ID: 20370447 [TBL] [Abstract][Full Text] [Related]
39. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man. Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826 [TBL] [Abstract][Full Text] [Related]
40. Platelet-related hemostasis before and after hemodialysis with five different anticoagulation methods. Knehtl M; Ponikvar R; Buturovic-Ponikvar J Int J Artif Organs; 2013 Oct; 36(10):717-24. PubMed ID: 24254839 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]